Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Indo Premier Sekuritas, a leading private securities firm, recognizes that innovation is essential for enhancing quality of life and fostering solutions that elevate societal welfare across all demographics. Interestingly, the physical distancing measures implemented during the Covid-19 pandemic served as a catalyst for the Indo Premier innovation team, leading to increased productivity and the development of a robust application-based stock transaction platform. This period of social distancing heightened public awareness regarding the necessity of a comprehensive stock trading application. In response to this demand, Indo Premier proudly introduces the IPOT application, which represents a significant step toward business transformation and addresses customer feedback for a powerful and all-encompassing trading solution. The launch of IPOT not only signifies a technological advancement but also aligns with the company's commitment to meet the evolving needs of investors in a rapidly changing market.
Description
Protocol First not only connects disparate locations and dismantles barriers in Clinical Research during the pandemic, but its offerings remain valuable during regular times as well. What was once viewed as optional technology has now become essential. Our solutions facilitate ongoing communication, enabling research not just to persist but to thrive and progress at an accelerated pace. Featuring a fully integrated remote monitoring tool equipped with automatic tagging, our system operates seamlessly with any EDC, anytime, and from any location. Protocol First prioritizes the integration of Sites, Sponsors, CROs, and various functional areas to create a cohesive research environment. We provide holistic solutions that tackle the numerous challenges faced in Clinical Research. The foundation of Protocol First is ensuring accuracy and proper placement of your data, which increasingly incorporates AI, NLP, and ML technologies. A critical component of utilizing AI effectively is establishing a robust structure for your data. The suite of software offered by Protocol First guarantees that data flows efficiently from patients to the FDA, maximizing the potential of data science and enhancing the overall research process. As we move forward, our commitment to innovation will continue to evolve, further amplifying our impact in the field.
API Access
Has API
No
API Access
Has API
No
Integrations
Mekari Qontak
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
Yes
iPad App
Yes
Android App
Yes
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Indo Premier Securities
Founded
2002
Country
Indonesia
Website
www.indopremier.com/article.php
Vendor Details
Company Name
Protocol First
Website
www.protocolfirst.com
Product Features
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
No
Document Management
No
Electronic Data Capture
No
Enrollment Management
No
HIPAA Compliant
No
Monitoring
No
Patient Database
No
Recruiting Management
No
Scheduling
No
Study Planning
No
Electronic Data Capture
Audit Trail
No
CRF Tracking
No
Data Entry
No
Data Verification
No
Distributed Capture
No
Document Imaging
No
Document Indexing
No
Forms Management
No
Remote Capture
No
Study Management
No